Charles Schwab’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.4M Buy
660,438
+17,464
+3% +$452K ﹤0.01% 1854
2025
Q4
$16.3M Buy
642,974
+62,278
+11% +$1.39M ﹤0.01% 1875
2025
Q3
$9.36M Sell
580,696
-80,450
-12% -$1.3M ﹤0.01% 2149
2025
Q2
$10.6M Buy
661,146
+34,534
+6% +$522K ﹤0.01% 1985
2025
Q1
$10.7M Buy
626,612
+62,170
+11% +$1.3M ﹤0.01% 1921
2024
Q4
$14M Buy
564,442
+12,012
+2% +$341K ﹤0.01% 1871
2024
Q3
$15.7M Buy
552,430
+91,259
+20% +$2.69M ﹤0.01% 1822
2024
Q2
$12.2M Buy
461,171
+19,087
+4% +$543K ﹤0.01% 1946
2024
Q1
$14.3M Buy
442,084
+5,004
+1% +$183K ﹤0.01% 1806
2023
Q4
$18.4M Buy
437,080
+49,840
+13% +$1.83M ﹤0.01% 1642
2023
Q3
$14.9M Sell
387,240
-26,904
-6% -$608K ﹤0.01% 1690
2023
Q2
$7.86M Buy
414,144
+25,677
+7% +$479K ﹤0.01% 2021
2023
Q1
$6.03M Buy
388,467
+1,813
+0.5% +$31.5K ﹤0.01% 2118
2022
Q4
$6.86M Buy
386,654
+81,679
+27% +$1.03M ﹤0.01% 2042
2022
Q3
$1.7M Sell
304,975
-157
-0.1% -$767 ﹤0.01% 2625
2022
Q2
$1.19M Buy
305,132
+7,017
+2% +$30.3K ﹤0.01% 2729
2022
Q1
$1.64M Buy
298,115
+7,183
+2% +$44.7K ﹤0.01% 2714
2021
Q4
$2.48M Buy
290,932
+21,554
+8% +$178K ﹤0.01% 2630
2021
Q3
$2.34M Sell
269,378
-65,058
-19% -$587K ﹤0.01% 2663
2021
Q2
$3.54M Buy
334,436
+2,949
+0.9% +$41.2K ﹤0.01% 2516
2021
Q1
$5.32M Buy
331,487
+27,713
+9% +$731K ﹤0.01% 2272
2020
Q4
$14M Buy
303,774
+55,181
+22% +$2.55M 0.01% 1650
2020
Q3
$8.75M Buy
248,593
+92,890
+60% +$2.79M ﹤0.01% 1780
2020
Q2
$3.79M Buy
+155,703
New +$3.34M ﹤0.01% 2158

Other funds holding IMVT